Agoracom Blog Home

Posts Tagged ‘stocks’

VIDEO: CEO LiveChat – ThreeD Capital $IDK.ca $IDKFF $IP.ca $IPNFF $GMBL

Posted by AGORACOM-JC at 3:21 PM on Tuesday, September 1st, 2020
IDK-square-for-blog

Why ThreeD Capital?

Discovering Great Disruptive Companies

ThreeD Capital provides investors with significant exposure to ground floor opportunities in

  • Small cap stocks in their very early stages;
  • Disruptive Technologies

that would otherwise be impossible for 99% of investors to participate in.  There is quite simply no other investment vehicle like it in the Canadian small cap space. 

Best of all, investors get to invest in ThreeD Capital under the leadership of one of the greatest investors in Canadian history – Sheldon Inwentash, the Founder, Chairman and CEO. When Sheldon Inwentash speaks, listeners stand to make a lot of money.  His track record speaks for itself.

PyroGenesis $PYR.ca Announces Completion and Acceptance of Modelling Contract with Iron Ore Pelletization Client A; Receives Draft Contract for Equipment Purchase $RTN $NOC $UTX $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 3:13 PM on Tuesday, September 1st, 2020
  • Announced the completion and acceptance of its modeling contract with Client A which confirmed, amongst other things, that replacing fossil fuel burners with PyroGenesis’ proprietary plasma torches addresses the Client’s greenhouse gas reduction strategy/policy
  • PyroGenesis is also pleased to confirm receipt of a draft equipment purchase contract from Client A
  • Client’s name shall remain anonymous for competitive and confidential reasons

MONTREAL, Sept. 01, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, further to its press release dated July 2nd, 2020, is pleased to announce the completion and acceptance of its modeling contract with Client A (the “Client”) which confirmed, amongst other things, that replacing fossil fuel burners with PyroGenesis’ proprietary plasma torches addresses the Client’s greenhouse gas reduction strategy/policy. PyroGenesis is also pleased to confirm receipt of a draft equipment purchase contract (the “Contract”) from Client A. The Client’s name shall remain anonymous for competitive and confidential reasons.

The modeling contract, disclosed in previous press releases, successfully demonstrated the benefits of replacing fossil fuel burners with PyroGenesis’ proprietary plasma torches. More specifically, two of the most important benefits demonstrated were i) that replacing fossil fuel burners with plasma torches was a simple replacement, plug and play process, and ii) that PyroGenesis’ proprietary plasma torches significantly reduce greenhouse gas emissions which, as a result, could play a significant role in Client A’s greenhouse gas reduction strategy/policy.

The Company also confirms having received a Contract which essentially highlights the terms and conditions negotiated to date. Although the major terms and conditions contained therein have been agreed to in principle, there are still several elements that need further review.

“The fact that we have received this Contract, on the heels of a successful modelling contract, from a significant player in the industry, clearly demonstrates the impact that PyroGenesis’ proprietary plasma torches are having in iron ore pelletization greenhouse gas reduction strategies,” said Mr. Peter Pascali, CEO and President of PyroGenesis. “Of note, PyroGenesis has the patent with respect to using plasma torches in iron ore pelletization as described. I must caution that although all parties are confident of the outcome, and the remaining details are minor, there is no guarantee that the Contract will, at the end of the day, be signed, until it is. We have no definite visibility on how long this will take but we are clearly in the final stages. We are all very excited at the significant role PyroGenesis’ proprietary plasma torches could play in reducing greenhouse gases, economically, all to the benefit of our planet.”

Pelletization is the process in which iron ore is concentrated before shipment, thus significantly reducing the cost of transportation. In conventional technologies, the process heat is provided by fuel oil or natural gas burners (both environmentally damaging). The combustion, in the burners, of fossil fuels results in the production of greenhouse gases, mainly CO2. Plasma torches, by contrast, utilize renewable electricity and as such offer an environmentally attractive alternative to fossil fuel burners.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]

Primo Nutraceuticals Inc. $PRMO.ca and Dan Duquette Former MLB Executive Enter into Letter of Intent for the Development of a Global Supply of #PPE products & Primo Hand Sanitizer

Posted by AGORACOM-JC at 8:50 AM on Tuesday, September 1st, 2020
  • Entered into a Letter of Intent with Duquette Consulting LLC (the “LOI”), a company owned by Dan Duquette.
  • Dan Duquette is a twice named Major League Baseball (MLB) Executive of the Year and former Executive Vice-President of the Baltimore Orioles, General Manager of the Montreal Expos, Boston Red Sox, and Milwaukee Brewers
  • Dan Duquette has joined forces with Primo Nutraceuticals to partner in the development, sourcing and the global supply of personal protective equipment products including Primo’s hand sanitizer

VANCOUVER, British Columbia, Sept. 01, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce it has entered into a Letter of Intent with Duquette Consulting LLC (the “LOI”), a company owned by Dan Duquette. Dan Duquette is a twice named Major League Baseball (MLB) Executive of the Year and former Executive Vice-President of the Baltimore Orioles, General Manager of the Montreal Expos, Boston Red Sox, and Milwaukee Brewers (https://en.wikipedia.org/wiki/Dan_Duquette). Dan Duquette has joined forces with Primo Nutraceuticals to partner in the development, sourcing and the global supply of personal protective equipment (“PPE”) products including Primo’s hand sanitizer.

In June 2020 Primo received its first shipment of its lemon hand sanitizer and immediately began sending out samples to procurement departments, receiving positive feedback regarding the quality of the product. Duquette Consulting & their affiliates will help Primo in marketing the hand sanitizer via their partnership channels, marketing brochures & e-commerce sites exposing the Company’s products on a global scale. As Primo is expanding into the Canadian market the Company must have an MDEL (Medical Device Establishment License) to comply with the regulations of Health Canada relating to companies seeking to sell, distribute, manufacture or import medical equipment in Canada. Primo and Duquette Consulting will work towards securing the necessary licenses required to sell nitrile gloves, N95 surgical masks & KN95 masks and gowns. The Company is extremely focused on developing the right partnerships that will encourage the Company’s growth into the market sector of health and wellness. Primo is extremely optimistic that building these strategic types of relationships will prove fruitful for the Company and its shareholders in the very near future.

Duquette Consulting entered the PPE market by sourcing and selling products and supplies at a government & state level to help in the fight against COVID-19, securing, shipping and recently delivering over 5 million masks to the State of Maryland in the United States (the “U.S”). Duquette Consulting partnered with Crowley Worldwide (www.crowley.com) a large logistics conglomerate with over USD $2 billion in annual revenue, offering services to the U.S. Department of Defense, the Department of Homeland Security and other state and federal agencies in the U.S.; top medical equipment suppliers, with financial backing by Citibank. A Duquette Consulting press release is located at the following link: https://dcppe.net/case-study/

The strategic partnership contemplated in the LOI is extremely beneficial for Primo, opening the doors to potential massive orders for the Company’s hand sanitizer worldwide. With the recent issuance of a Government Procurement number to Primo by the Canada Revenue Agency and the LOI with Duquette Consulting LLC, Primo could soon be able to bid on government tenders not only for hand sanitizer, but for N95 surgical masks, KN95 masks, nitrile surgical gloves and gowns. All PPE products would meet the certification standards of the market place including the FDA, CDC, MOD and NIOSH approval requirements.

Richard Cindric, CEO of Primo comments:“We are excited to partner with Mr. Duquette. Together we will provide our line of hand sanitizer to Dan’s already established PPE supply chain processes and distribution network of companies across the U.S.A. and abroad.”

Andy Jagpal, President of Primo comments: “We are extremely pleased to partner with Mr. Duquette to develop a global supply chain of personal protection equipment. We look forward to working with Dan and his team.”

Dan Duquette, CEO Duquette Consulting LLC comments: “Our new partnership with Primo contemplated in the LOI will afford Duquette Consulting the opportunity to broaden our offerings to those in need of PPE.  Our recent success in supplying the State of Maryland with over five millions NIOSH approved Surgical Masks is a prime example of our ability to meet the need of institutional buyers who are looking for both quality products from a reputable firm who can deliver in an expedient and cost effective manner. As well as adding in our ability to finance our transactions is a significant differentiator that separates us in the PPE marketplace.”

Joel DeBellefeuille, Director of Primo comments: ”I’ve known Dan for a few years now and I couldn’t be happier to continue working and collaborating with him on amazing deals and partnerships. This is a major plus for Primo and its shareholders. Dan is an extremely influential person with a network of people spanning the globe.”

About Dan Duquette

Dan Duquette is a MLB veteran (Major League Baseball) Executive whose leadership built winning teams and enterprise value of club and media assets over an 18 year career. Successfully executing plans to immediately turn around the Montreal Expos, Boston Red Sox and Baltimore Orioles as entertaining teams to grow fan base, improve revenues, expand market share and improve content distribution. He is also the founder of the Dan Duquette Sports Academy. He has twice been named the Major League Baseball Executive of the Year by Sporting News in 1992 with the Expos and in 2014 with the Baltimore Orioles.

About Duquette Consulting LLC

Duquette Consulting is a management consulting company. With the advent of the worldwide pandemic, we have focused our efforts to help combat the effects of COVID19. In doing so, we established a network of international companies and entities who specialize in supporting the emergency management community in times of crisis. As part of our covid-19 initiative, Duquette Consulting manages and coordinates the procurement and acquisition for both the public and private sectors, domestically and internationally of Personal Protection Equipment (PPE). Our partnership has banking relationships that allow Duquette Consulting’s Partnership group the ability to finance large scale supply of PPE items such as masks, gloves and gowns. Our products are of the highest quality and meet the certifications standards of the marketplace including the FDA, CDC, MOD, and NIOSH approval requirements.

About Primo Nutraceuticals

Primo Nutraceuticals Inc. (“Primo” or the “Company”) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

Andy Jagpal

Andy Jagpal
President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected].

To learn more about what this news means to the shareholders visit:

www.primonutraceuticals.com
www.twitter.com/Prmoinc
www.thrivecbd.com
www.mariannacorp.com
www.dcppe.net

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.

TGS Esports Announces Intent to Acquire Leading Competitive #Esports Platform, Pepper Esports $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 8:45 AM on Tuesday, September 1st, 2020
TGS-square
  • Executed a letter of intent dated August 28, 2020 to acquire Pepper Esports Inc.
  • Pepper platform offers an advanced suite of tools for league operators, tournament operators, and venue owners to setup and manage esports communities and run world class events
  • These include key innovations, such as Pepper’s automatic game scoring technology, which uses its patent pending AI engine and saves event organizers hundreds of hours of setup time, while also providing players and attendees with a vastly improved experience.

VANCOUVER, BC, Sept. 1, 2020  – TGS Esports Inc. (“TGS” or the “Company“) (TSX-V: TGS) is pleased to announce that it has taken the next step in its growth strategy to provide a consolidated end to end esports experience to players and tournament organizers by executing a letter of intent dated August 28, 2020 (the “LOI“) to acquire Pepper Esports Inc. (“Pepper“), a leading competitive esports platform (the “Acquisition“). In addition, the Pepper executive team, Guy Halford-Thompson, Jackson Warren and Ben Hoffman, with over a decade of combined experience in growing early stage companies in the public markets, are expected to join TGS executive team on the closing of the Acquisition (the “Closing“). Under the terms of the LOI, TGS is expected to acquire all of the outstanding securities of Pepper by way of a three-cornered amalgamation.

The Pepper platform offers an advanced suite of tools for league operators, tournament operators, and venue owners to setup and manage esports communities and run world class events. These include key innovations, such as Pepper’s automatic game scoring technology, which uses its patent pending AI engine and saves event organizers hundreds of hours of setup time, while also providing players and attendees with a vastly improved experience.

Transaction Highlights

  • Develop New Revenue Streams – the Acquisition is expected to provide TGS with diverse new online revenue streams that include data monetization, payment processing and recurring subscription revenue.
  • Expanded Consumer and Business Base – the combined company will have the ability to acquire users from all over the globe through tournaments of any kind.
  • Highly Accomplished and Experienced Team – the completion of the Acquisition will add a team with over a decade of combined experience in growing early stage companies in the public markets.

“Rather than sending our players to third party platforms for online events, and missing out on key revenue, we will now be able to keep players within our ecosystem while also generating revenue directly from the Pepper platform,” said Spiro Khouri, CEO of TGS. “This acquisition brings an important technology platform to TGS, making our business model scalable, global, and with defensible IP.”

“This acquisition will fast track our ability to scale the Pepper platform by leveraging the existing customers and expertise of the TGS team, and we hope to bring accelerated revenue growth to TGS once the Pepper platform is fully launched,” said Guy Halford-Thompson, CEO of Pepper. “Becoming part of TGS is a big milestone for the company.”

The global market for esports tournaments is expected to be USD $1.598 billion by 2023 according to an August 2020 report by Statista, with few dominant game-agnostic service providers that are publicly traded.

Summary of Acquisition

The LOI sets out the principal terms on which the parties have agreed to complete the Acquisition. The parties have agreed to negotiate in good faith to formalize a definitive agreement (the “Definitive Agreement“) on or before October 30, 2020, and they have agreed to a mutual exclusivity and due diligence period expiring 45 days from the date of the LOI.

On Closing, the Company will acquire all of the issued and outstanding common shares of Pepper (the “Pepper Shares“) in consideration for 43,385,664 common shares of the Company (each a “TGS Share“, and such TGS Shares issued as consideration for the Acquisition, the “Consideration Shares“) at a deemed price of $0.14 per Consideration Share for aggregate deemed consideration of approximately $6,073,993. The Consideration Shares will be subject to a contractual lock-up, with 20% of the Consideration Shares being released on the Closing and a further 20% being released every six months thereafter.

Each outstanding security of Pepper that is convertible or exchangeable for Pepper Shares will be exchanged for corresponding securities that are convertible or exchangeable for TGS Shares on substantially the same economic conditions.

On Closing, Pepper will have the right to appoint a nominee to the board of directors of the Company.

The LOI contains, and the Definitive Agreement will provide for, customary representations, warranties and covenants including non-solicitation and a right to match any superior proposal. Completion of the Acquisition remains subject to a number of conditions, including: (i) the approval of the Acquisition by the shareholders of Pepper, (ii) the completion of satisfactory due diligence, (iii) the approval of the boards of directors of the Company and Pepper, (iv) the execution of the Definitive Agreement, (v) obtaining all required consents, waivers and approvals, including the approval of the TSX Venture Exchange, and (vi) other closing conditions customary for transactions of this nature.

Haywood Securities Inc. has acted as a financial advisor to Pepper in connection with the Acquisition.

The Company and Pepper deal at arm’s length with each other, and the Acquisition is not expected to result in a change of control of the Company.  A finder’s fee in an amount to be determined at a later time may be payable in connection with the Acquisition, subject to compliance with applicable securities laws and the approval of the TSXV.

About Pepper Esports Inc.

Pepper is a leading esports platform provider that offers an advanced platform to create and manage communities of players, organizers, spectators and sponsors, all in one place.  By working closely with event organizers and live venue operators over the last two years, Pepper has developed a suite of advanced tools to manage esports communities, run world class esports and operate physical gaming venues.

Pepper’s key technologies include its patent pending AI engine, which automatically captures game data to create a tournament experience that extends beyond live gameplay and includes highly demanded features such as global leaderboards, player profiles and statistics, new tournament discovery and digital wallets.

About TGS Esports Inc.

TGS Esports Inc. is the parent company of Myesports. Myesports was created in Vancouver, British Columbia, in 2018, and is an esports organization focused on providing and hosting esports events, tournaments, and leagues at both the amateur and professional levels both online and in person. Myesports is the operator of Canada’s first dedicated esports arena, The Gaming Stadium, located in Richmond, British Columbia, which opened in June 2019.  Since its inception, Myesports has hosted esports events for games such as League of Legends and Fortnite, as well as organized and hosted the Pinnacle event at the River Rock Casino and the Burnaby Festival of Learning. Myesports also hosts regular online tournaments as well as provides high quality broadcast production for any event. For more information, visit www.thegamingstadium.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

On behalf of the Board of Directors

Spiro Khouri

Spiro Khouri, CEO
TGS Esports Inc.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including with respect to: Guy Halford-Thompson, Jackson Warren and Ben Hoffman joining the TGS team, that the Acquisition will allow the Company to keep players within its ecosystem while also generating revenue directly from the Pepper platform, that the Acquisition will make the Company’s business model scalable, global, and with defensible IP, that the Acquisition will fast track Pepper’s ability to scale the Pepper platform by leveraging the existing customers and expertise of the TGS team the execution of the Definitive Agreement and the terms of such Definitive Agreement, the completion of the Acquisition, the acceptance of the TSX Venture Exchange, the global market for esports tournaments and that a finder’s fee may be payable in connection with the Acquisition. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. The risks include the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic and other risks that are customary to transactions of this nature. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them.

This press release is not an offer of the securities for sale in the United States. The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful.

PyroGenesis $PYR.ca Participates in $HPQ.ca Non-Brokered Private Placement Financing $IDK.ca $DUK $XEL $NEE

Posted by AGORACOM-JC at 8:26 AM on Tuesday, September 1st, 2020
  • Announced that it is closing a non-brokered private placement of 4,500,000 units (“Unit”) at $0.60 per Unit for gross proceeds of $2,700,000 with the two following Placees:
  • PyroGenesis Canada Inc(TSX-V: PYR), a high-tech company, that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products has subscribed for 4,000,000 units in the placement for a gross proceeds of $2,400,000;
  • THREED CAPITAL INC. (CSE: IDK) (OTTCBB: IDKFF) a Canadian venture capital firm that invests in disruptive companies has subscribed for 500,000 units in the placement for a gross proceeds of $300,000.

MONTREAL, Sept. 01, 2020 — HPQ Silicon Resources Inc. (“HPQ” or “the Company”) TSX-V: HPQ; FWB: UGEOther OTC : URAGF; is pleased to announce that it is closing a non-brokered private placement of 4,500,000 units (“Unit”) at $0.60 per Unit for gross proceeds of $2,700,000 with the two following Placees:

  • PyroGenesis Canada Inc(TSX-V: PYR), a high-tech company, that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products has subscribed for 4,000,000 units in the placement for a gross proceeds of $2,400,000;
  • THREED CAPITAL INC. (CSE: IDK) (OTTCBB: IDKFF) a Canadian venture capital firm that invests in disruptive companies has subscribed for 500,000 units in the placement for a gross proceeds of $300,000.

“This transaction is a further demonstration of the strength of the HPQ – PyroGenesis cooperation as we develop both the PUREVAP™ Quartz Reduction Reactor (QRR) and the PUREVAP™ Nano Silicon Reactor (NSiR) processes.  Furthermore, the participation of legendary Venture Capital Financier Sheldon Inwentash in a Private Placement that values HPQ market capitalization over the $150 Million threshold is strong vote of confidence in what we are doing,” said Bernard Tourillon, President & CEO of HPQ Silicon. “Our PUREVAP™ processes open up unique business opportunities with multibillion-dollar addressable markets for HPQ, PyroGenesis and our shareholders, as we strive to deliver the critical Silicon nano-materials required by the surging Li-ion battery market and other renewable energy sectors.”

“It is indeed a pleasure to participate in this private placement and increase our position in HPQ,” said P. Peter Pascali CEO and Chairman of PyroGenesis Canada Inc. “Not only do we find this to be a unique opportunity to invest in a business that has enormous potential for growth, but one that is supported by a visionary management and Board. We are confident that this investment will play out very well for us and our investors, and we look forward to consider adding to our position should the opportunity arise in the future.”

In addition to participating in the Placement, HPQ is pleased to announce that THREED Capital Inc CEO Sheldon Inwentash has agreed to act as a strategic advisor to HPQ management as we embark in the start of this new and exciting phase of our development.

Placement Terms: Each Unit will be comprised of one (1) common share and one (1) common share purchase warrant (“Warrant”) of the Company. Each Warrant will entitle the Subscribers to purchase one common share of the capital stock of the Company at an exercise price of $ 0.61 for a period of 36 months from the date of closing of the placement. Each share issued pursuant to the placement will have a mandatory four (4) month and one (1) day hold period from the date of closing of the placement. The Placement is subject to standard regulatory approvals.

About Silicon

Silicon (Si), also known as silicon metal, is one of today’s strategic materials needed to fulfil the Renewable Energy Revolution (“RER”) presently under way. Silicon does not exist in its pure state; it must be extracted from quartz (SiO2), in what has historically been a capital and energy intensive process.

About HPQ Silicon

HPQ Silicon Resources Inc. (TSX-V: HPQ) is a Canadian producer of Innovative Silicon Solutions, based in Montreal,  building a portfolio of unique high value specialty silicon products needed for the coming RER.

Working with PyroGenesis Canada Inc. (TSX-V: PYR), a high-tech company that designs, develops, manufactures and commercializes plasma – based processes, HPQ is developing:

  • The PUREVAP™ “Quartz Reduction Reactors” (QRR), an innovative process (patent pending), which will permit the one step transformation of quartz (SiO2) into high purity silicon (Si) at reduced costs, energy input, and carbon footprint that will propagate its considerable renewable energy potential;
       °  HPQ believes it will become the lowest cost (Capex and Opex) producer of silicon (Si) and high purity silicon metal (3N – 4N Si);
  • The PUREVAP™ Nano Silicon Reactor (NSiR), a new proprietary process that can use different purities of silicon (Si) as feedstock, to make spherical silicon nanopowders and nanowires;
       °  HPQ believes it can also become the lowest cost manufacturer of spherical Si nanopowders and silicon-based composites needed by manufacturers of next-generation lithium-ion batteries;
       °  During the coming months, spherical Si nanopowders and nanowires silicon-based composite samples requested by industry participants and research institutions’ will be produced using PUREVAP™ SiNR.

HPQ is also working with industry leader Apollon Solar of France to:

  • Use their patented process and develop a capability to produce commercially porous silicon (Si) wafers and porous silicon (Si) powders;
       °  The collaboration will allow HPQ to become the lowest cost producer of porous silicon wafers for all-solid -state batteries and porous silicon powders for Li-ion batteries.
       °  The plan is to deliver porous Si wafer to a battery manufacturer (under NDA) for testing in 2020.

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

Disclaimers:

The Corporation’s interest in developing the PUREVAP™ QRR and any projected capital or operating cost savings associated with its development should not be construed as being related to the establishing the economic viability or technical feasibility of any of the Company’s Quartz Projects.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the security’s regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011
Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239
http://www.hpqsilicon.com Email: [email protected]

ThreeD Capital Inc. $IDK.ca $IDKFF Provides Corporate Developments $IP.ca $IPNFF $GMBL

Posted by AGORACOM-JC at 7:39 AM on Tuesday, September 1st, 2020
IDK-square-for-blog
  • Company is pleased to announce it is now disclosing the number of junior resource and technology investments on its newly designed website and will update these figures at the commencement of each month
  • In the last month, ThreeD increased the number of junior resource investments from 12 to 15, representing a 25% increase month over month
  • The Company plans to continue to grow its junior resource portfolio for the foreseeable future

TORONTO, Sept. 01, 2020 — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF) a Canadian based venture capital firm that invests in disruptive companies and promising junior resources companies, is pleased to provide a general corporate update to shareholders.

ThreeD is actively investing in the junior resource sector and has significantly grown its number of junior resource investments for the last 3 consecutive months.

The Company is pleased to announce it is now disclosing the number of junior resource and technology investments on its newly designed website and will update these figures at the commencement of each month. In the last month, ThreeD increased the number of junior resource investments from 12 to 15, representing a 25% increase month over month. The Company plans to continue to grow its junior resource portfolio for the foreseeable future.   

ThreeD previously reported in its continuous disclosure documents that it had sold pursuant to a share purchase agreement dated November 15, 2019, an aggregate of 13,500,000 common shares of New Found Gold Corp. to a third party purchaser at a price of $0.08 per share for aggregate proceeds of $1,080,000. The Company has since commenced a legal action claiming rescission of the transaction or, in the alternative, damages in the approximate amount of $16,000,000 or the present value of the common shares. The Company is currently arranging with the third party dates and times for discoveries in this action.  The Company believes that the purchaser was in possession of information material to the transaction that was not disclosed at the time. It is not determinable if the Company will be successful in its claim or, if successful, the amount of damages that may be awarded, if any.

About ThreeD Capital Inc.

ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the Junior Resources, Artificial Intelligence, Blockchain, Esports, Renweable Technology, Internet of Things, & Nanotechnology sectors. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and is actively involved with investees by advising and leveraging ThreeD’s powerful network.

Forward-Looking Statements

This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to the legal action concerning the common shares of New Found Gold Corp. (the “Litigation”). All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur including, without limitation, risks relating to the timing, costs and potential outcome of the Litigation. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.

For further information:
Gerry Feldman, CPA, CA
Chief Financial Officer and Corporate Secretary
[email protected]
Phone: 416-941-8900 ext 106

Empower Clinics $CBDT.ca Announces Acquisition of Medical Diagnostics Laboratory $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:06 AM on Tuesday, September 1st, 2020

Empower intends to acquire Kai Medical Laboratory, a state-of-the-art diagnostics laboratory located in the medical district of Dallas, TX to advance COVID-19 national testing programs

  • Entered into a non-binding term sheet to acquire the business of Kai Medical Laboratory, LLC, by way of a share or asset acquisition, subject to due diligence and customary closing conditions
  • Kai Medical Laboratory is a high-complexity CLIA and COLA accredited Laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups
  • Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology

VANCOUVER, BC / September 1, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (“Empower” or the “Company“) today announces it has entered into a non-binding term sheet to acquire the business of Kai Medical Laboratory, LLC (“Kai Medical Laboratory“), by way of a share or asset acquisition, subject to due diligence and customary closing conditions.

Kai Medical Laboratory is a high-complexity CLIA and COLA accredited Laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups. Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology. These tests are done under the supervision of its well-qualified and highly experienced scientists, medical professionals, and pharmacists. https://www.kaimedicallaboratory.com

Kai Medical Laboratory has taken an active role in COVID-19 testing, battling the pandemic through RT-PCR testing and serology testing. While the RT-PCR test identifies if a patient has an active virus, the serology or antibody test detects if a patient has previously been exposed to the virus. Both of these test results are vital to managing outbreaks and the potential spread of coronavirus.

To further assist with COVID-19 testing, Kai Medical Laboratory has also developed two key programs in Texas and Arizona. The first program is a direct-to-consumer program that leverages the ability of various healthcare providers to order and administer both the RT-PCR test and the Antibody test. This increases the ability of the general population to be tested, in certain circumstances. The second is an Employer COVID-19 Compliance Program (ECCP) for business owners and employer groups to enable them to test and monitor their employees.

Texas program https://www.testtexasnow.com

Arizona program https://www.covidtest2u.com

Currently the lab has the capacity to complete in excess of 2,000 RT-PCR tests in one eight-hour shift by utilizing its Thermo Fisher QuantStudio 12k Flex testing machine. The lab also utilizes a Roche Cobas 6000 for COVID-19 Antibody testing, ensuring that Kai Medical Laboratory has the capability and capacity to serve a broad range of clients and test methods.

“Adding Kai Medical Laboratory to the Empower Clinics family enables us to dramatically expand COVID-19 testing capability and deliver phase four of our national rollout plan” said Steven McAuley, Empower’s Chairman & CEO. “Kai Medical has a newly built high-complexity lab offering a wide array of testing services, that together we will leverage to serve the massive demand for national COVID testing in the U.S. Further, as flu season arrives and a potential second-wave of COVID takes hold, the technical infrastructure of Kai Medical allows Empower to capture testing demand and the additional growth revenues associated with it.”

The driving force behind Kai Medical Laboratory’s remarkable growth and success is Yoshi Tyler. Yoshi has a passion for being an entrepreneur, and overtime, she found her true calling in healthcare. Driven by this interest, she pursued her career in the healthcare industry for more than two decades. She helmed leadership positions at a Fortune 500 pharmaceutical company for over thirteen years. These leadership experiences provided her with in-depth knowledge and industry insights that helped her to lead Kai Medical Laboratory towards growth.

The Kai Medical Laboratory team includes key roles including Principal Scientist, Director of Operations, Molecular Scientist, Quality Assurance, Lab Director and other critical roles.

“Kai Medical Laboratory is inspired by science and built on integrity. Our mission is to change healthcare through science & innovative quality care by providing value-added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in healthcare,” says Yoshi Tyler, the owner, and CEO of the company.

The proposed acquisition includes an 8,000 sq. ft. medical laboratory including covered drive up testing center, with premium testing and laboratory equipment, cash and current assets with a value in excess of $1,750,000.00 USD and a corporate office, both located in the heart of the medical district in Dallas, TX. Under the proposed terms Empower will assume a $1,200,000.00 USD Small Business Administration (SBA) equipment loan, a $150,000.00 SBA Economic Injury Disaster Loan and short-term liabilities of up to $250,000.00 at closing. In addition, Empower will issue 1,000,000 Company stock options to the Vendors, subject to the terms and conditions as set out in the Company Stock Option Plan.

Market Leading Technology Kai Medical Laboratory utilizes state-of-the-art instrumentation, preeminent testing methodologies, and laboratory services enabling high-complexity accredited laboratory testing solutions, providing some of the following key instrument testing capabilities:

  • Thermo Fisher – QuantStudio 12K Flex
    • COVID-19 testing
    • Cannabis Testing
    • Clinical Genomics
  • Roche Cobas 6000
    • COVID-19 Antibody testing
    • Clinical Chemistry/Endocrinology
  • AB SCIEX 6500+ – Liquid Chromatography Mass Spectrometry
    • Clinical Chemistry/Endocrinology
    • Agriculture/Cannabis testing
  • AB SCIEX 4500 – Liquid Chromatography Mass Spectrometry
    • Urine Toxicology
    • Cannabis testing
  • SYSMEX XN-550
    • Hematology

USA COVID-19 Data as at August 31, 2020

TOTAL CASES: 5,972,356

TOTAL DEATHS: 182,622

CASES IN LAST 7 DAYS: 289,865

ARIZONA as at August 31, 2020

CONFIRMED CASES: 199,984

PROBABLE CASES: 1,713

TOTAL CASES: 201,661

CASES IN LAST 7 DAYS: 3,558

CASES/100K: 1,769

DEATHS/100K: 70

TEXAS as at August 31, 2020

TOTAL CASES: 610,354

CASES IN LAST 7 DAYS: 32,817

CASES/100K: 2,126

DEATHS/100K: 46

(CLIA) The Clinical Laboratory Improvement Amendments regulate laboratory testing and require clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing.

(COLA) is the premier clinical laboratory accreditation, education and consultation organization. An independent accreditor whose practical, educational standards have a positive and immediate impact on patient care. http://www.cola.org

The transaction is expected to be structured on a tax efficient basis, and otherwise in accordance with the requirements of requisite securities laws and the policies of the CSE. Empower has agreed to enter into employment agreements with Yoshi Tyler and Michael Haines, each having an initial term of two years.

Completion of the transaction will be subject to various conditions, including entry into a definitive agreement, completion of due diligence, and receipt of all required shareholder, manager, third party and regulatory approvals, including approval of the CSE. Closing of the transaction is expected to occur prior to October 15, 2020.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative.

ABOUT KAI MEDICAL LABORATORY

Our mission is to change healthcare through science & innovative quality care by providing value added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in patient care. Kai Medical Laboratory is located in the Dallas Medical District in close proximity to some of the largest healthcare groups in the U.S. including Parkland Hospital, UT Southwestern, Children’s Medical Center, Baylor Scott & White Health (Dallas), Tenet Healthcare (Dallas), CHRISTUS Healthcare (Dallas).

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Dustin Klein

Director
[email protected]
720-352-1398

Investors: Steven McAuley

CEO
[email protected]
604-789-2146

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the proposed acquisition of Sun Valley; the proposed transaction terms; the expected number of clinics and patients following the closing; the future potential success of Sun Valley’s franchise model; the anticipated date of closing of the acquisition and the occurrence thereof; and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

END OF DAY ALERT – Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Up 30% To All-Time Closing High On 1.9M Shares $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 5:21 PM on Monday, August 31st, 2020
kontrol-logo

Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Reports Second Quarter 2020 Results $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 5:01 PM on Monday, August 31st, 2020
kontrol-logo
  • Kontrol continues to focus on strengthening its Balance Sheet. The Company’s cash position at the end of Q2 is approximately $1.8 Million
  • During the second quarter of 2020 the Company announced the commencement of a non-brokered private placement (with an exchange of units) of up to $5.8 million principal amount 8% unsecured (and non-convertible) debentures maturing on October 31, 2022
  • Company is developing its BioCloud technology and has a achieved a number of significant milestones, including the initial funding from the Government, positive testing of the detection mechanism, and positive testing of the BioCloud fully operational prototype.

TORONTO, ON / August 31, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company”) a leader in the energy efficiency sector through IoT, Cloud and SaaS technology announces its financial results for the six months ended June 30, 2020.

A complete set of Financial Statements and Management’s Discussion & Analysis will be filed on SEDAR (www.sedar.com) on August 31, 2020. A call to discuss the financial results has been scheduled for Monday, August 31, 2020 at 4:30pm (EST). See details below.

“In Q2 2020 we were able to navigate the complex business challenges presented by COVID-19 and make important strategic advances while maintaining positive EBITDA and cash flow from operations,” says Paul Ghezzi, CEO. “This environment has made it challenging to gain access to customer sites for projects; however, our recurring revenue and service platform have performed very well. In addition, we initiated the development of the Kontrol BioCloud, a new technology designed to detect and alert for the COVID-19 virus. We continue to fund all BioCloud development through internal cash generation. Kontrol does not need to raise capital to operate its business.”

Subsequent to the second quarter end, the Company completed the acquisition of New Found Air (“NFA”) – a building service and solutions company. The operations of NFA are in the process of being merged with Kontrol’s existing platform. NFA expands Kontrol’s building footprint and provides an established customer base with a potential significant cross-selling platform for Kontrol’s smart building technology.

Q2 2020 Financial Summary

Strengthened Financial Position

Kontrol continues to focus on strengthening its Balance Sheet. The Company’s cash position at the end of Q2 is approximately $1.8 Million. During the second quarter of 2020 the Company announced the commencement of a non-brokered private placement (with an exchange of units) of up to $5.8 million principal amount 8% unsecured (and non-convertible) debentures maturing on October 31, 2022. The Company intends to allocate up to $5.8 million of the units for issuance to holders of 2020 debenture units who wish to exchange their 2020 debenture units for units in the offering. The Company anticipates that the majority of unitholders will exchange their units in the months of September and October.

The Company closed the first tranche of non-brokered private placement for 2023 Convertible Debenture Proceeds in the second quarter of net $1.05 million and an additional approximate $900,000 subsequent to the second quarter. The completion of the financing was primarily allocated to the closing of the NFA acquisition

FY 2020 Outlook

The Company continues to strategically focus on the growth of its recurring revenues. With the recently completed acquisition of NFA and the existing customer base, approximately 30% of all revenues are now recurring. The Company’s goal is to drive recurring revenues towards 50% of all total revenues by the end of 2021.

While there appears to be a general improvement with site access to customer facilities there is also ongoing uncertainty presented by COVID-19 travel restrictions and self-quarantine. These conditions make it difficult to forecast project revenues and provide any guidance. Any previous guidance will be retracted, and the Company will continue to provide ongoing reporting and announce larger project revenues as they are generated.

Kontrol BioCloud

The Company is developing its BioCloud technology and has a achieved a number of significant milestones, including the initial funding from the Government, positive testing of the detection mechanism, and positive testing of the BioCloud fully operational prototype. The Company seeks to complete testing with the live COVID-19 virus during the week of August 31 and will provide those results when available. The Company’s objective is to have BioCloud commercially available to potential customers in 2020. There is no assurance that the Company can achieve this internal goal.

About Kontrol BioCloud

BioCloud is a real-time analyzer developed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.

* Adjusted EBITDA is a non-IRFS financial measure. The Company defines Adjusted EBITDA as net income or loss before interest, income taxes, amortization, and depreciation, share based compensation, and acquisition related expenses.

Conference Call Details:

Title:Kontrol Energy Second Quarter 2020 Financial Results
Event Date:Monday, August 31, 2020 – 4:30PM Eastern Time
Event Duration:60 Minutes
Event Link:Webcast URL https://www.webcaster4.com/Webcast/Page/2402/37011
Participant Number:Toll Free: 877-407-0782
International: 201-689-8567


Please connect at least 5 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast.

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada’s fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean’s.


Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.


For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

Certain information included in this press release, including information relating to future financial or operating performance and other statements that express the expectations of management or estimates of future performance constitute “forward-looking statements”. Such forward-looking statements include, without limitation, statements regarding possible future acquisitions and/or investments in operating businesses and/or technologies, accelerated organic growth, Adjusted EBITDA, expansion of smart energy technologies into US markets, strategic partnerships to expand into North American Markets, acceleration of recurring SaaS revenues, the provision of solutions to customers and Greenhouse Gas emissions reductions, proposed financial savings and sustainable energy benefits and energy monitoring. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief are based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that suitable businesses and technologies for acquisition and/or investment will be available, that such acquisitions and or investment transactions will be concluded, that sufficient capital will be available to the Company, that technology will be as effective as anticipated, that organic growth will occur, and others.. However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications. Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and the Company does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise, except as required under applicable securities law.

SOURCE: Kontrol Energy Corp.

AGORACOM Welcomes FansUnite $FANS.ca The Small Cap iGaming Super Company $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 4:51 PM on Monday, August 31st, 2020
Fans-100

The global online gambling market could potentially hit $1 TRILLION by the end of this decade.  That is not a typo and the obvious reasons include the following:

1.  Exponential growth in the number of people online.  Yet only 59% of the world means more to come. 

2.  Fast growth in the number of countries and jurisdictions legalizing gambling to collect tax revenue.

3.  Explosive growth in gambling options beyond casino and sports betting.  Fantasy, Esports, etc.

Until recently, however, small-cap investors did not have a company that could provide them ground floor exposure to this massive market and its growth over the next 10 years.  The industry was dominated by the big traditional gambling companies, who focus heavily on old fashioned gambling. 

That all changes with FansUnite, the small cap iGaming super company that goes beyond simple gambling and attacks both sides of the iGaming market by offering:

B2C (Business To Consumer)          Gambling platforms that provide services directly to gamblers

B2B (Business To Business) Gambling technology for companies that already have gamblers

The formation of this iGaming super company became a reality when FansUnite acquired Askott Entertainment recently, the highlights of which are as follows:  

  • $27,000,000 Acquisition
  • Over $350,000,000 In Total Bets
  • Over 300,000 Registered Users
  • Rare combination of B2C + B2B Gambling In Small Cap
    • B2C – 4 Platforms
    • B2B –  4 Deals Signed; 2 Are Already Live
  • Askott has integrated over over 6,000 Casino Games Onto Platform
  • $5,000,000 financing closed in support of acquisition
  • World renowned team
Fans-200
Fans-300

For those of you who don’t know what Esports is, it can easily be described as the professionalization of video games.  Whereas video game players were once stereotyped as basement dwelling geeks, today’s top esports players and teams make millions of dollars competing in online tournaments that are watched by millions of people around the world …. 520,000,000 to be exact.

If you think that number is astounding, consider the fact it will grow to 650,000,000 by 2022.

To put the size of esports into perspective, by 2021, esports is projected to have more viewers than every major sports league in the world except the NFL.

….. AND THEY GAMBLE ….A  LOT!

Esports revenues from betting are set to hit record highs in 2020, with revenues expected to double from $7 billion in 2019 to $14 billion, due in no small part to the Covid-19 crisis.

With this massive market up for grabs, the acquisition of Askott provides FANS with a strong opportunity to capture meaningful market share thanks to the following:

  • Recognized globally as a leader and pioneer in esports betting technology
  • Launch of the first ever daily fantasy site dedicated to esports
  • First esports betting site to receive an Isle of Man gaming license in 2017
  • Shortlisted by EGR Magazine for the Esports Betting Supplier of the Year Award.
Fans-400

WHAT IS THE DIFFERENCE BETWEEN GAMING AND GAMBLING?

The main difference between the terms is that for gaming the outcome is achieved by skill, not chance, whereas for gambling, the opposite is true

FANS-500
FANS10000

THE FANSUNITE LINEUP – B2C

FANS-700
FANS-800

McBookie is a leading provider of betting services under a license to operate granted by the U.K. Gambling Commission. McBookie focuses on B2C offerings and has strategically decided to pursue an underserved market, focusing on the Scottish market and clientele. McBookie has been in operation for over a decade.

  • 10,000 active members
  • $135M CAD betting volume last 3 years
  • Sports betting, Casino & Virtual Sports
  • Delivered a Year over Year increase in Gross Gaming Revenue over the Q2 period of 131%.
    • Majority of that has been delivered by the casino where YOY turnover in Q2 was up 59% from $2.4M CAD to $3.9M CAD, resulting in a gross margin increase of 191%.
FANS-900

ESP.BET & ESPORTSPOOLS.com – Esports Betting · Esports Daily Fantasy · Esports Casino

  • Combined the sites have over 200,000 registered users in 160+ countries
  • Both using the Chameleon Esports Platform
  • ESP.bet was the first esports betting site licensed in the Isle of Man
  • Esportspools.com was the first dedicated esports fantasy site
FANS-1000
  • Latest site to launch on the Chameleon esports betting platform.
  • LATAM focused brand and an example of the platforms flexibility to launch highly localized sites.
  • Currently supports 10 languages and can localize to additional languages as needed.
FANS-1100

In the hyper growth iGaming world, speed is everything and FANS is on the move in 2020 with partnerships, licenses, acquisitions and new markets in the works, including ENTERING THE US MARKET by the end of this year.  Have a look at the FANS roadmap.

FANS-1200
FANS-1300

FansUnite provides investors with all the elements necessary to earn its place as the leading small cap iGaming company including:

  • Real Products
  • Real Customers
  • Real Revenues
  • Proven Technology
  • Rapid Growth
  • Clear Growth Plan
  • Global Scalability
  • Fully Diversified Business With Both B2B and B2C Operations
  • Powerful Lineup Of Digital Properties
  • And Last But Not Least For Every Small Cap Company …….. Fully Funded
FANS-1400

OVERTIME – THE FANSUNITE LINEUP – IN ACTION

FANS-1500
FANS-1600